Drug loaded magnetic nanoparticles for cancer therapy

Journal of Physics Condensed Matter

Volumn 18, Issue 38, 2006, Pages

  Jurgons, R ^a   Seliger, C ^a   Hilpert, A ^a   Trahms, L ^b   Odenbach, S ^c   Alexiou, C ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC CELL SEPARATION; MAGNETIC DRUG TARGETING; MAGNETIC NANOPARTICLES; NANOSIZED DRUG DELIVERY;

BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; DRUG DOSAGE; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; NANOSTRUCTURED MATERIALS;

ONCOLOGY;

EID: 33749533577     PISSN: 09538984     EISSN: 1361648X     Source Type: Journal    
DOI: 10.1088/0953-8984/18/38/S24     Document Type: Article

References (41)

1. Stechell C H 1985 Magnetic separations in biotechnology-a review J. Chem. Technol. Biotechnol. 35B 175
2. Olsvik O, Popovic T, Skjerve E, Cudjoe K S, Hornes E, Ugelstad J and Uhlen M 1994 Magnetic separation techniques in diagnostic microbiology Clin. Microbiol. Rev. 7 43-54
3. Safarikova M and Safarik I 2001 Immunomagnetic separation of Escherichia coli O26, O111 and O157 from vegetables Lett. Appl. Microbiol. 33 36-9
4. Deponte S, Steingroewer J, Löser C, Boschke E and Bley T 2004 Biomagnetic separation of Escherichia coli by use of anion-exchange beads: measurement and modeling of the kinetics of cell-bead interactions Anal. Bioanal. Chem. 379 419-26
5. Durcova-Hills G, Tokunaga T, Kurosaka S, Yamaguchi M, Takahashi and Imai H 1999-2000 Immunomagnetic isolation of primordial germ cells and the establishment of embryonic germ cell lines in the mouse Cloning 1 217-24
6. Brooimans R A, de Leeuw N, Bontenbal M and Gratama J W 2005 An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies J. Biol. Regul. Homeost. Agents. 19 84-91
7. Varshney M, Yang L, Su X L and Li Y 2005 Magnetic nanoparticle-antibody conjugates for the separation of Escherichia coli O157:H7 in ground beef J. Food. Prot. 68 1804-11
8. Lekowska-Kochaniak A, Czajkowska D and Kokowski J 2002 Detection of Escherichia coli O157:H7 in raw meat by immunomagnetic separation and multiplex PCR Acta Microbiol. Pol. 51 327-37
9. Safarik I and Safarikova M 1999 Use of magnetic techniques for the isolation of cells J. Chromatogr. B 722 33-5
10. Stark D D, Weissleder R, Elizondo G, Hahn P F, Saini S, Todd L E, Wittenberg J and Ferucci J T 1988 Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver Radiology 168 297-301
11. Suzuki M, Honda H, Kobayashi T, Wakabayashi T, Yoshida J and Takahashi M 1996 Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles Brain Tumor Pathol. 13 127-32
12. Weissleder R, Cheng H C, Bogdanova A and Bogdanov A 1997 Magnetically labeled cells can be detected by MR imaging J. Magn. Reson. Imaging 7 258-63
13. Pouliquen D, Perdrisot R, Ermias A, Akoda S, Jallet P and Jeune J J 1989 Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: contribution of microencapsulation to improved biodistribution Magn. Reson. Imaging 7 619-27
14. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H and Kaiser W A 2002 Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study Invest. Radiol. 37 580-6
15. Jordan A, Wust P, Scholz R, Tesch B, Fähling H, Mitrovics T, Vogl T, Cervos-Navarro J and Felix R 1996 Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro Int. J. Hyperthermia 12 705-22
16. Jordan A, Scholz R, Wust P, Fähling H and Felix R 1999 Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles J. Magn. Magn. Mater. 201 413-9
17. Jordan A, Scholz R, Maier-Hauff K, van Landeghem F K, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A and Felix R 2005 The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma J. Neurooncol. 29 1-8
18. Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y and Murakami T 2000 Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters Int. J. Oncol. 17 309-15
19. Alksne J F, Fingerhut A and Rand R 1966 Magnetically controlled metallic thrombosis of intracranial aneurysms Surgery 60 212-8
20. Ito A, Shinkai M, Honda H and Kobayashi T 2005 Medical application of functionalized magnetic nanoparticles J. Biosci. Bioeng. 100 1-11
21. Torchilin V P 2000 Drug targeting Eur. J. Pharm. Sci. 11 81-91
22. Gao Y 2005 Biofunctionalization of magnetic nanoparticles Biofunctionalization of Nanomaterials ed C S Kumar (Winheim: Wiley-VCH) pp72-98
23. Tiefenauer L X, Tschiky A, Kühne G and Andres R Y 1996 In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI Magn. Reson. Imaging 14 391-402
24. Müller R H, Jakobs C and Kayser O 2001 Nanosuspensions as particulate drug formulations in therapy-Rational for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 3-19
25. Sachdeva M S 1998 Drug targeting systems for cancer therapy Expert Opin. Invest. Drugs. 7 1849-64
26. Storm G, Belliot S O, Daemen T and Lasic D D 1995 Suface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 31-48
27. Alexiou C, Jurgons R, Schmid R, Bergemann C, Henke J, Erhardt W, Huenges E and Parak F G 2003 Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent Mitoxantron after locoregional cancer treatment J. Drug Target. 11 139-49
28. Alexiou C, Arnold W, Klein R, Parak F G, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S and Lübbe A S 2000 Locoregional cancer treatment with magnetic drug targeting Cancer Res. 60 6641-8
29. Alexiou C, Arnold W, Hulin P, Klein R J, Renz H, Parak F G, Bergemann C and Lübbe A S 2001 Magnetic mitoxantrone nanoparticle detection by histology, x-ray and MRI after magnetic drug targeting J. Magn. Magn. Mater. 225 187-93
30. Alexiou C, Arnold W, Hulin P, Klein R, Schmidt A, Bergemann C and Parak F G 2001 Therapeutic efficacy of ferrofluid bound anticancer agent Magnetohydrodynamics 37 318-22
31. Alexiou C, Schmid R J, Jurgons R, Kremer M, Wanner G, Bergemann C, Huenges E, Nawroth T, Arnold W and Parak F G 2006 Targeting cancer cells: magnetic nanoparticles as drug carriers Eur. Biophys. J. 35 446-50
32. Collins J M 1984 Pharmacological rationale for regional drug delivery J. Clin. Oncol. 2 498-505
33. Gupta P K and Hung C K 1990 Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic fields in rats Life Sci. 46 471-84
34. Gupta P K and Hung C K 1990 Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin mirospheres in rats J. Microencapsul. 7 85-92
35. Gupta P K 1990 Drug targeting in chemotherapy: a clinical perspective J. Pharm. Sci. 79 949-62
36. Alexiou C, Jurgons R, Seliger C, Brunke O, Iro H and Odenbach S 2006 Anticancer Res. at press
37. Wiekhorst F, Jurgons R, Eberbeck D, Sander T, Steinhoff U, Hartwig S, Alexiou C and Trahms L 2005 SQUID system with integrated superconducting shield for monitoring of drug targeting with magnetic nanoparticles in animals Biomed. Tech. 50 609-10
38. Alexiou C, Jurgons R, Seliger C, Kolb S, Heubeck B and Iro H 2006 Fluorescence microscopic investigations on VX2 squamous cell carcinoma cells Z. Phys. Chem. 220 235-40
39. Alexiou C, Jurgons R, Schmid R, Hilpert H, Bergemann C, Parak F G and Iro H 2005 In vitro and in vivo investigations of targeted chemotherapy with magnetic particles J. Magn. Magn. Mater. 293 389-93
40. Alexiou C, Jurgons R, Schmid R, Erhardt W, Parak F G, Bergemann C and Iro H 2005 Magnetisches drug targeting-ein neuer ansatz in der lokoregionären tumortherapie mit chemotherapeutika HNO 53 618-22
41. Brigger I, Morizet J, Laudani L, Aubert G, Appel M, Velasco V, Terrier-Lacombe M J, Desmaele D, d'Angelo J, Couvreur P and Vassal G 2004 Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model J. Control. Release 100 29-40